TSTickerStar
Company alerts/LGVN
LGVN company alerts

LGVN updates worth following

TickerStar monitors official filings, investor releases, earnings, and call updates for LGVN. Subscribe to LGVN alerts to receive concise, source-linked alerts when TickerStar detects a meaningful company update.

Official-source feed

Recent LGVN alert previews

TickerStar filters routine noise and surfaces investor-relevant filings, releases, earnings, and call updates.

SEC filingSEC filing

LGVN 10-Q filed 2026-11-12 | Key takeaways

LGVN filed its 10-Q; the most relevant disclosure change is added Strategic alternatives and going concern: Company initiated strategic alternatives review process with Special Committee formed October 8, 2026 and retained Lucid Capital Markets as financial advisor October 28, 2026 to explore potential business combination; cash flow forecast indicates insufficient. Customer concentration: Customer One represented 100% of revenue; Customer One represented 100% of revenue.

Read source-backed brief
Company updateOfficial company source

Longeveron Inc. announces Chief Medical Officer departure

On October 7, 2026, Dr. Nataliya Agafonova informed management of her decision to step down as Chief Medical Officer of Longeveron Inc., effective October 14, 2026. The company filed the current report on Form 8-K under Item 5.02(b) to disclose the departure. The 8-K did not include a transition plan, interim replacement, or other compensatory details.

Read source-backed brief